Radiotherapy for Peyronie's Disease: A European survey

Acta Oncologica

Volumn 47, Issue 6, 2008, Pages 1110-1112

  Incrocci, Luca ^a   Hop, Wim C J ^a   Seegenschmiedt, Heinrich M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; PAIN ASSESSMENT; PATIENT REFERRAL; PEYRONIE DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; TREATMENT OUTCOME;

DOSE FRACTIONATION; EUROPE; HEALTH CARE SURVEYS; HUMANS; MALE; PENILE INDURATION; QUESTIONNAIRES; RADIOTHERAPY DOSAGE;

EID: 51149106580     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801910379     Document Type: Article

References (8)

1. Trott KR, Kamprad F. Radiobiological mechanisms of antiinflammatory radiotherapy. Radiother Oncol 1999;51:197-203.
2. Little MP. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol 2001;2:212-20.
3. Devine CJ, Somers KD, Jordan GH, Schlossberg SM. Proposal: Trauma as the cause of the Peyronie's lesion. J Urol 1997;157:285-90.
4. Pryor JP, Ralph DJ. Clinical presentation of Peyronie's disease. Int J Impot Res 2002;14:414-7.
5. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: A survey. Radiother Oncol 1998;48:249-57.
6. Incrocci L. Radiotherapeutic treatment of Peyronie's disease. Expert Rev Pharmacoeconomics Outcome Res 2004;4:235-42.
7. Mourits MP, van Kempen-Harteveld ML, García MBG, Koppeschaar HPF, Tick L, Terwee CB. Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study. Lancet 2000;355:1505-9.
8. Incrocci L, Wijnmaalen A, Slob AK, Hop WCJ, Levendag PC. Low-dose radiotherapy in 179 patients with Peyronie's Disease: Treatment outcome and current sexual functioning. Int J Radiat Oncol Biol Phys 2000;47:1353-6.